Thomas Duley

Mar 22, 2023 | lexology.com | Michael E. Borden |Meenakshi Datta |Thomas Duley |Cassidy A. Pomeroy-Carter

Leadership of the U.S. Senate and House Armed Services Committees recently announced the full roster of biotechnology and national security commissioners for the National Security Commission on Emerging Biotechnology (Commission). This commission’s recommendations may influence national policy in areas relevant to biopharmaceutical companies, such as funding opportunities, data-sharing mandates and prohibitions, and cross-border activities.